RT Journal Article
T1 Plazomicin activity against 346 extended-spectrum-beta-lactamase/AmpC producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes
A1 López Díaz, María Carmen
A1 Culebras López, Esther
A1 Rodríguez-Avial Infante, Iciar
A1 Ríos Dueñas, Esther
A1 Viñuela Prieto, José Manuel
A1 Picazo De La Garza, Juan José
A1 Rodríguez-Avial López-Doriga, Carmen
AB The activity of plazomicin and clinically relevant aminoglycosides was tested against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates, and the results were correlated with the presence of aminoglycoside-modifying enzymes (AMEs). Data showed that plazomicin was very active against all ESBL/AmpC-producing E. coli urinary isolates. Its activity was not related to the AME genes studied.
PB American Society for Microbiology
SN 0066-4804
YR 2016
FD 2016-12-05
LK https://hdl.handle.net/20.500.14352/112723
UL https://hdl.handle.net/20.500.14352/112723
LA spa
NO López-Diaz MDC, Culebras E, Rodríguez-Avial I, Rios E, Viñuela-Prieto JM, Picazo JJ, Rodríguez-Avial C. 2017. Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes. Antimicrob Agents Chemother 61:10.1128/aac.02454-16. https://doi.org/10.1128/aac.02454-16
NO National R&D Plan, AES 2013
NO Instituto de Salud Carlos III
NO Unión Europea
DS Docta Complutense
RD 7 abr 2025